GLP-1/Exendin-4 induces β-cell proliferation via the epidermal growth factor receptor
Abstract Exendin-4 is a long acting glucagon-like peptide 1 (GLP-1) analogue that is an agonist for the GLP-1 receptor, a G-protein coupled receptor (GPCR). Exendin-4 is used to clinically improve glucose tolerance in diabetic patients due to its ability to enhance insulin secretion. In rodents, and...
Main Authors: | Joseph Fusco, Xiangwei Xiao, Krishna Prasadan, Qingfeng Sheng, Congde Chen, Yung-Ching Ming, George Gittes |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-09898-4 |
Similar Items
-
Evaluation of an [18F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma
by: Dale O. Kiesewetter, Ning Guo, Jinxia Guo, Haokao Gao, Lei Zhu, Ying Ma, Gang Niu, Xiaoyuan Chen
Published: (2012-01-01) -
Effects of GLP-1(9-36) and exendin-4 on glucagon secretion from human islets of Langerhans: evidence of a novel GLP-1 receptor in islets?
by: Ramracheya, R, et al.
Published: (2014) -
GLP-1 and exendin-4 increase post-prandial leptin in type 2 diabetes
by: Stoeckli, R, et al.
Published: (2005) -
Brain Imaging of the GLP-1 Receptor in Obesity Using <sup>68</sup>Ga-NODAGA-Exendin-4 PET
by: Laura N. Deden, et al.
Published: (2021-12-01) -
Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward.
by: Rozita H Shirazi, et al.
Published: (2013-01-01)